Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement

Authors

Rob Arbuckle, Adelphi Values, Cheshire, UK
Louise Humphrey, Adelphi Values, Cheshire, UK
Lucy Abraham, Pfizer Ltd., Kent, UK
Lorraine Dennerstein, University of MelbourneFollow
James A. Simon, George Washington UniversityFollow
Sebastian Mirkin, Pfizer, Inc., Collegeville, PA
Nicola Bonner, Adelphi Values, Cheshire, UK
Steven Walmsley, Adelphi Values, Cheshire, UK
Sophi Tatlock, Adelphi Values, Cheshire, UK
Tara Symonds, Pfizer Ltd., Kent, UK

Document Type

Journal Article

Publication Date

7-2014

Journal

Maturitas

Volume

Volume 78, Issue 3

Inclusive Pages

219-227

Keywords

Estrogen Replacement Therapy--adverse effects; Metrorraghia--etiology; Postmenopause; Quality of Life; Questionnaires; Uterine Hemorrhage--etiology

APA Citation

Arbuckle, R., Humphrey, L., Abraham, L., Dennerstein, L., Simon, J.A. et al. (2014). Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools. Maturitas, 78(3), 219-227.

Peer Reviewed

1